Apollo Endosurgery to Present at Piper Sandler Healthcare Conference
Apollo Endosurgery (Nasdaq:APEN), a leader in less invasive medical devices, announced participation in the 32nd Annual Piper Sandler Healthcare Conference on December 1-2, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Apollo Endosurgery (Nasdaq:APEN), a leader in less invasive medical devices, announced participation in the 32nd Annual Piper Sandler Healthcare Conference on December 1-2, 2020. The management will engage in virtual one-on-one meetings, with a pre-recorded fireside chat available for Piper Sandler clients. Investors wishing to attend or schedule meetings can contact their Piper Sandler representative or Apollo's investor relations.
Apollo specializes in device-based therapies for gastrointestinal conditions, operating in over 75 countries.
Details
News Market Reaction – APEN
The recorded move for APEN in the trading session of this news was +3.92%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
AUSTIN, TX / ACCESSWIRE / November 23, 2020 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in the 32nd Annual Piper Sandler Healthcare Conference.
December 1-2, 2020
32nd Annual Piper Sandler Healthcare Conference
Apollo management will participate in virtual one on one meetings. A fireside chat overview presentation has been pre-recorded and will be available to Piper Sandler clients.
Investors interested in attending the virtual presentation or arranging meetings should contact their respective Piper Sandler representative or Apollo's investor relations, Matt Kreps of Darrow Associates, mkreps@darrowir.com.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.
Contacts:
Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com
Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com
SOURCE: Apollo Endosurgery, Inc.
View source version on accesswire.com:
https://www.accesswire.com/617985/Apollo-Endosurgery-to-Present-at-Piper-Sandler-Healthcare-Conference
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.